When you hear the word “ketamine,” you might think of club drugs or even anesthesia. But in recent years, ketamine—and its close cousin, esketamine (Spravato)—has been receiving much attention in
Depression and Cardiovascular Disease
Depression and cardiovascular disease (CVD) are two of the most pervasive and disabling health conditions globally—and mounting evidence shows that they are deeply interconnected. Heart disease continues to be the
Breaking the Cycle of Treatment-Resistant Depression: Real-World Lessons from Europe
Treatment-resistant Depression (TRD) poses a significant challenge in mental health care. Despite the availability of various antidepressant therapies, a substantial subset of patients fails to achieve response or remission, leading
Enhancing Depression Treatment: The Synergistic Potential of TMS and Antidepressants
Major Depressive Disorder (MDD) stands as a leading cause of disability worldwide, affecting millions and imposing significant personal and societal burdens. Traditional treatment modalities, primarily pharmacotherapy with antidepressants, have shown
Can Exercise Treat Depression?
Depression: A Growing Global Challenge Depression is one of the world’s leading causes of disability, affecting over 280 million people worldwide. Traditional treatments—such as antidepressants and psychotherapy—help many, but they’re
Antidepressant Weight Gain: A Recent Study
In the landscape of mental health treatment, antidepressant medications play a crucial role in managing conditions like Depression. However, patients and clinicians often express concern about potential side effects, with
Can Spravato (Esketamine) Transform Treatment-Resistant Depression? Insights from a Recent Study
Treatment-resistant Depression (TRD) remains one of Psychiatry’s most complex clinical challenges. Standard antidepressants often fail to bring relief to approximately one-third of patients with Major depressive disorder (MDD). In this
Comparing TMS With Other Antidepressant Treatments
In the evolving landscape of mental health treatments, finding effective solutions for treatment-resistant Depression (TRD) remains a significant challenge. As many as one third of patients with major depressive disorder
A New Era in Mental Health: Ketamine-Based Therapies for Treatment-Resistant Depression
Depression is not a one-size-fits-all disorder. While many people find relief with traditional antidepressant treatments, approximately 30% of patients diagnosed with major depressive disorder (MDD) fall into the category of treatment-resistant
Can Maintenance TMS Prevent Relapse in Depression? The Latest Research
Major Depressive Disorder (MDD) is a complex and often recurrent condition that affects millions of people worldwide. While treatments such as antidepressant medications and psychotherapy have proven effective for many,